• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征前驱期阿尔茨海默病的症状和发病年龄:系统评价和荟萃分析。

Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis.

机构信息

Department of Clinical Genetics, Juntendo University, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.

The Medical Center for Dementia, Juntendo Hospital, Tokyo, Japan.

出版信息

Neurol Sci. 2024 Jun;45(6):2445-2460. doi: 10.1007/s10072-023-07292-9. Epub 2024 Jan 16.

DOI:10.1007/s10072-023-07292-9
PMID:38228941
Abstract

The diagnostic criteria for adult-onset Alzheimer's disease (AD) in patients with Down syndrome (DS) have not been standardised. This study investigated the specific symptoms of AD in the prodromal stage of DS, the mean age at diagnosis at each stage of dementia, and the relationship between intellectual disability (ID) and dementia. PubMed, Web of Science, and Embase were searched for studies on DS, AD, early-stage disease, initial symptoms, and prodromal dementia registered between January 2012 and January 2022. We also performed a meta-analysis of the differences between the mean age at prodromal symptoms and AD diagnosis and the proportion of mild cognitive impairment in patients with mild and moderately abnormal ID. We selected 14 articles reporting the behavioural and psychological symptoms of dementia (BPSD) and memory- and language-related impairments as early symptoms of AD in patients with DS. The specific symptoms of BPSD were classified into five categories: irritability (agitation), apathy, abnormal behaviour, adaptive functioning, and sleep disturbance. The mean age at the diagnosis of prodromal symptoms and AD dementia was 52.7 and 56.2 years, respectively (mean difference, + 3.11 years; 95% CI 1.82-4.40) in the meta-analysis. The diagnosis of mild dementia tended to correlate with ID severity (odds ratio [OR], 1.38; 95% CI 0.87-2.18). The features of behaviour-variant frontotemporal dementia may be clinically confirmed in diagnosing early symptoms of DS-associated AD (DSAD). Moreover, age-appropriate cognitive assessment is important. Further studies are required to evaluate DSAD using a combination of biomarkers and ID-related data.

摘要

用于唐氏综合征(DS)患者的成人发病型阿尔茨海默病(AD)诊断标准尚未标准化。本研究调查了 DS 疾病前阶段 AD 的特定症状、痴呆各阶段的诊断平均年龄,以及智力障碍(ID)与痴呆的关系。通过PubMed、Web of Science 和 Embase 检索了 2012 年 1 月至 2022 年 1 月期间发表的关于 DS、AD、早期疾病、初始症状和疾病前痴呆的研究。我们还对疾病前症状和 AD 诊断的平均年龄差异以及轻度和中度异常 ID 患者轻度认知障碍的比例进行了荟萃分析。我们选择了 14 篇报告 DS 患者 AD 早期症状的行为和心理症状的痴呆(BPSD)和记忆及语言相关障碍的文章。BPSD 的特定症状分为五类:易怒(激越)、淡漠、异常行为、适应功能和睡眠障碍。疾病前症状和 AD 痴呆的诊断平均年龄分别为 52.7 和 56.2 岁(平均差异,+3.11 岁;95%CI 1.82-4.40)。轻度痴呆的诊断倾向于与 ID 严重程度相关(比值比[OR],1.38;95%CI 0.87-2.18)。行为变异型额颞叶痴呆的特征可能在诊断 DS 相关 AD(DSAD)的早期症状时得到临床确认。此外,进行适当年龄的认知评估很重要。需要进一步的研究来使用生物标志物和 ID 相关数据的组合来评估 DSAD。

相似文献

1
Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis.唐氏综合征前驱期阿尔茨海默病的症状和发病年龄:系统评价和荟萃分析。
Neurol Sci. 2024 Jun;45(6):2445-2460. doi: 10.1007/s10072-023-07292-9. Epub 2024 Jan 16.
2
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
3
Modified Cued Recall Test: Longitudinal Analysis of Test Versions and Item Recall in Adults With Down Syndrome.改良线索回忆测试:唐氏综合征成人患者测试版本及项目回忆的纵向分析
J Intellect Disabil Res. 2025 Apr 20. doi: 10.1111/jir.13237.
4
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
5
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
6
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
7
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
8
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
9
The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.唐氏综合征患者痴呆的早期表现:纵向研究的系统评价
Neuropsychol Rev. 2017 Mar;27(1):31-45. doi: 10.1007/s11065-017-9341-9. Epub 2017 Mar 13.
10
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.

引用本文的文献

1
Systematic review and evidence gap mapping of Alzheimer's disease biomarker studies in those with intellectual and developmental disability.智力和发育障碍者阿尔茨海默病生物标志物研究的系统评价与证据缺口图谱分析
Alzheimers Dement (Amst). 2025 Sep 1;17(3):e70175. doi: 10.1002/dad2.70175. eCollection 2025 Jul-Sep.
2
Mesenchymal stem cell application in Alzheimer's disease.间充质干细胞在阿尔茨海默病中的应用。
Regen Ther. 2025 Jul 26;30:439-445. doi: 10.1016/j.reth.2025.07.006. eCollection 2025 Dec.
3
Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome.

本文引用的文献

1
Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.唐氏综合征患者的智力障碍程度与阿尔茨海默病发病时间的关系。
J Alzheimers Dis. 2023;95(1):213-225. doi: 10.3233/JAD-230200.
2
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome.唐氏综合征成年患者中生物性别与阿尔茨海默病临床结局及生物标志物的关联。
Brain Commun. 2023 Mar 17;5(2):fcad074. doi: 10.1093/braincomms/fcad074. eCollection 2023.
3
Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities.
来自神经元的小细胞外囊泡的货物显示唐氏综合征患者痴呆症的进展。
Alzheimers Dement. 2025 Jun;21(6):e70380. doi: 10.1002/alz.70380.
使用严重损伤量表、简易实践测试和学习障碍者痴呆评定量表识别唐氏综合征患者中的痴呆症。
J Intellect Disabil Res. 2021 Dec;65(12):1085-1096. doi: 10.1111/jir.12901. Epub 2021 Nov 16.
4
Comprehensive Analysis of Brain Volume in REM Sleep Behavior Disorder with Mild Cognitive Impairment.伴轻度认知障碍的快速眼动睡眠行为障碍患者脑容量的综合分析
J Parkinsons Dis. 2022;12(1):229-241. doi: 10.3233/JPD-212691.
5
Alzheimer's disease associated with Down syndrome: a genetic form of dementia.唐氏综合征相关的阿尔茨海默病:一种遗传性痴呆。
Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.
6
Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing Models.唐氏综合征患者阿尔茨海默病前驱期的认知功能:模型比较
Brain Sci. 2021 Sep 16;11(9):1220. doi: 10.3390/brainsci11091220.
7
A Systematic Review of Unexplained Early Regression in Adolescents and Adults with Down Syndrome.唐氏综合征青少年和成人不明原因早期衰退的系统评价
Brain Sci. 2021 Sep 10;11(9):1197. doi: 10.3390/brainsci11091197.
8
Astrocytes in Down Syndrome Across the Lifespan.唐氏综合征患者一生中的星形胶质细胞
Front Cell Neurosci. 2021 Aug 18;15:702685. doi: 10.3389/fncel.2021.702685. eCollection 2021.
9
Acute Regression in Down Syndrome.唐氏综合征急性退化
Brain Sci. 2021 Aug 23;11(8):1109. doi: 10.3390/brainsci11081109.
10
The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.唐氏综合征痴呆行为和心理症状量表(BPSD-DS II):优化与进一步验证
J Alzheimers Dis. 2021;82(3):1371. doi: 10.3233/JAD-219007.